Developer docs
API playgroundTry for free, no card

Search company profiles

PharmX

Full company profile

uuid000h67c

Namestring
PharmX
Legal namestring
Pharmx Technologies Limited
Websiteurl
pharmx.com.au
Company typeenum
Public
Founded yearint
2006
Descriptiontext

PharmX Technologies Limited (ASX: PHX; OTCMKTS: PHXTF), headquartered in Sydney, Australia, operates the most extensive electronic ordering and invoicing platform for the Australian and New Zealand pharmacy sector. Founded in 2006, the company previously operated as Corum Group before rebranding to Pharmx under CEO Tom Culver in 2023. Its core product, the Gateway, is a cloud-based EDI (Electronic Data Interchange) solution that integrates directly with 18+ pharmacy point-of-sale systems—including Fred, Minfos, Toniq, RxOne, Simple Retail, POSWorks, Pronto, and Corum Health—to automate ordering and e-invoicing between 5,500+ pharmacies and suppliers. A complementary B2B eCommerce Marketplace platform, launched in November 2025, enables multi-vendor product discovery and checkout, and the PharmX Analytics add-on provides predictive modelling, category analytics, natural-language querying, and unrealised-revenue tracking on top of the underlying transaction data.

The business serves two primary customer segments: (i) retail pharmacies across Australia and New Zealand (segment penetration of 99% in Australia per the company), and (ii) pharmaceutical and consumer health suppliers and wholesalers (including Bayer, Blackmores, Haleon, Pfizer, Reckitt, L'Oréal, and the major wholesalers CH2, API, and Symbion). Pharmacies access the platform free of charge; revenue is generated via account- and volume-based supplier partnership fees, supplemented by an exclusive contract with the National Diabetes Services Scheme (NDSS) for government diabetes product distribution.

Go-to-market combines self-serve platform access for SMB pharmacies and mid-market suppliers with direct enterprise sales for large pharmacy chains and major brand suppliers. Distribution is anchored by a February 2026 multi-year strategic alliance with Sigma Healthcare, under which Pharmx became the preferred EDI service provider for Sigma's wholesale operations and Chemist Warehouse retail footprint, accompanied by Sigma subscribing for ~10% of Pharmx's issued share capital and obtaining a board seat. The platform processes approximately $20 billion in annual pharmacy transactions across 80,000+ products, with exposure to all major Australian pharmacy banners (Chemist Warehouse, Priceline, Terrywhite Chemmart, Amcal, and Wizard).

Short descriptiontext

PharmX Technologies (ASX: PHX) operates ANZ's leading pharmacy electronic ordering and invoicing platform, connecting 5,500+ pharmacies and major suppliers via EDI-integrated ordering, a B2B marketplace, and analytics tools, serving 99% of Australian pharmacies.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSydney, Australia
HQ citystring
Sydney
HQ countrystring
Australia
HQ regionstring
Oceania
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmacy ordering platform, electronic data interchange, B2B eCommerce marketplace, pharmaceutical supply chain, point-of-sale integration
Industry3 codes
PRIMARYHLACAKAI
Medication Inventory, Procurement & Supply Chain (Pharmacy)
Healthcare & Life Sciences/Digital Health & Health IT/ePrescribing, Medication Management & Pharmacy IT
SECONDARYCRAOAHAK
Pharmacy Benefit/Channel Services (PSAO, 340B Admin, Chargebacks/Rebates Ops)
SECONDARYHLAFALAI
Pharmacy Benefit Management (PBM) & Pharmacy Network Administration
Healthcare & Life Sciences/Healthcare Providers & Systems/Pharmacy & Medication Management Services
NAICS code1 code
  • Drugs and Druggists' Sundries Merchant Wholesalers424210
SIC code1 code
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
Product category
Pharmacy Supply Chain Software
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Supplier Partnership Fees
TypeSubscription Recurring
Description

Pharmx's commercial model is funded through account and volume-based fees from supplier partnerships. Some suppliers may pass these fees on to pharmacies at their discretion.

pharmx.com.au
2Strategic Alliance - Equity Investment
TypeLicensing Royalties
Description

Under the multi-year strategic alliance with Sigma Healthcare, Pharmx receives equity investment (~59.95 million shares representing 10% of issued capital) and pays Sigma an establishment fee of approximately $8.7 million.

retailpharmacymagazine.com.au
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
Pricing details1 tier
1Free for pharmacies - platform access and ordering services provided at no cost
ModelFreemiumBilling cadenceMonthly
Notes

Pharmacies can access Gateway, Marketplace, and core ordering services without charge. Suppliers fund the platform through account and volume-based commercial arrangements.

pharmx.com.au
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

PharmX operates an integrated electronic ordering and invoicing platform for the Australian and New Zealand pharmacy industry. Its core offering is the Gateway, an EDI solution that connects pharmacies and suppliers through point-of-sale systems for automated ordering and e-invoicing. The company also operates a B2B Marketplace for multi-vendor product discovery and checkout, an Analytics platform for supplier insights, and a StockView inventory management tool.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • 99% of Australian pharmacies use the Pharmx platform
+5 more records
Product overview1 text field

PharmX is a platform-plus-modules architecture providing integrated pharmacy ordering solutions across ANZ. The core products are the Gateway (EDI solution connecting pharmacies and suppliers through POS systems for automated ordering and e-invoicing) and the Marketplace (B2B eCommerce platform for product discovery and multi-vendor checkout). The Analytics module builds on these by leveraging the ordering data to deliver actionable insights including unrealised revenue tracking, category performance, and product catalogue enrichment. StockView adds inventory visibility. Together, these solutions facilitate over $20 billion in annual pharmacy transactions and provide access to 80,000+ products across 99% of Australian pharmacies.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership7 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-02-23
Description

Multi-year strategic alliance positioning Pharmx as the preferred EDI service provider for Sigma's wholesale and Chemist Warehouse retail operations across Australia and New Zealand. Under the agreement, Sigma will subscribe for approximately 59.95 million Pharmx shares representing 10% of Pharmx's issued share capital and obtain a board seat. Pharmx will pay Sigma an establishment fee of approximately $8.7 million. The partnership aims to modernise pharmacy supply chains by improving reliability, efficiency, and transparency.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Pharmx holds an exclusive contract with the NDSS, supporting government agency distribution to pharmacies across Australia.

3POS Vendors (Fred, Minfos, Toniq, RxOne, Simple Retail)
Strategic tierCoreTypeTechnology or Integration
Description

Pharmx integrates with all major point-of-sale vendors in the pharmacy industry including Fred, Minfos, Toniq, RxOne, and Simple Retail for seamless ordering and data synchronization.

pharmx.com.au
4Major Pharmacy Chains (Chemist Warehouse, Priceline, Terrywhite, Amcal, Wizard)
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Major pharmacy retail chains use Pharmx for ordering and supply chain management including Chemist Warehouse, Priceline, Terrywhite Chemmart, Amcal, and Wizard.

pharmx.com.au
5Major Suppliers (Bayer, Blackmores, Haleon, Pfizer, Reckitt, L'Oréal)
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Leading pharmaceutical and consumer health brands distribute through Pharmx including Bayer, Blackmores, Haleon, Pfizer, Reckitt, L'Oréal, and many others.

pharmx.com.au
6Wholesalers (CH2, API, Symbion)
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Major pharmaceutical wholesalers CH2, API, and Symbion connect to pharmacies through the Pharmx platform.

pharmx.com.au
7Pharmacy Groups (IPA, Chemsave, Chemist King, Discount Drug Stores, Pharmacy 777)
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Various pharmacy buying groups and banner groups use Pharmx including IPA, Chemsave, Chemist King, Discount Drug Stores, and Pharmacy 777.

pharmx.com.au
Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
1CoverMyMeds
TypeDirect peer
Description

CoverMyMeds (owned by McKesson) operates a leading US electronic prior authorization and benefit verification platform for pharmacies and prescribers. It is a directly comparable two-sided health IT platform monetising pharmacy-supplier-payer connectivity.

TypeDirect peer
Description

MedAdvisor (ASX: MDR) is an Australian digital medication management and patient adherence platform serving pharmacies. It targets the same ANZ pharmacy customer base as PharmX and competes for pharmacy technology wallet share, though focused on patient-facing workflows rather than procurement.

3McKesson
TypeBroad incumbent
Description

McKesson is a global pharmaceutical wholesaler and owner of CoverMyMeds, with its own pharmacy ordering and supply chain platforms. It serves as the broad incumbent against which PharmX's ANZ-scale pharmacy network competes in capability breadth if not geographic overlap.

TypeDirect peer
Description

Surescripts operates the dominant US electronic prescribing network connecting prescribers, pharmacies, payers, and PBMs. Its two-sided health data exchange model and pharmacy-side integration footprint closely mirror PharmX's EDI/marketplace architecture for ANZ pharmacies.

TypeBroad incumbent
Description

Cardinal Health is a leading US pharmaceutical wholesaler and operator of the OutcomesMTM and pharmacy services platforms. It is comparable as a broad incumbent integrating wholesale distribution with pharmacy technology and analytics.

6PDX
TypeDirect peer
Description

PDX provides pharmacy software, clinical programs, and EDI/ordering technology solutions to US independent and chain pharmacies. Its pharmacy-facing ordering and supplier integration stack is functionally analogous to PharmX's Gateway offering.

TypeDirect peer
Description

RedSail Technologies provides pharmacy management software, clinical solutions, and pharmacy supply chain technology across thousands of US independent pharmacies. Its combined dispensing and procurement technology footprint is closely comparable to PharmX's Gateway-plus-Marketplace model.

8RxBenefits
TypeEmerging player
Description

RxBenefits provides PBM technology, pharmacy benefit administration, and pharmacy supply chain analytics to employer health plans. It shares the supplier-pharmacy-payer data monetisation thesis with PharmX but focuses on US benefit administration rather than ordering infrastructure.

TypeEmerging player
Description

OrderInsite is a US pharmacy inventory analytics and demand planning vendor serving chain and independent pharmacies. It overlaps with PharmX's newer Analytics/StockView modules, but lacks the EDI and marketplace layer.

TypeBroad incumbent
Description

Cencora (formerly AmerisourceBergen) is a major US pharmaceutical distributor with embedded pharmacy services technology and Good Neighbor Pharmacy provider programs. It represents the broad incumbent equivalent of PharmX's supplier-pharmacy network at global scale.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat7 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration19 records

Each record includes

Title, Type, Description, Source

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance7 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

PharmX

Pharmacy Supply Chain Softwarepharmx.com.au

PharmX Technologies (ASX: PHX) operates ANZ's leading pharmacy electronic ordering and invoicing platform, connecting 5,500+ pharmacies and major suppliers via EDI-integrated ordering, a B2B marketplace, and analytics tools, serving 99% of Australian pharmacies.

What PharmX does

PharmX Technologies Limited (ASX: PHX; OTCMKTS: PHXTF), headquartered in Sydney, Australia, operates the most extensive electronic ordering and invoicing platform for the Australian and New Zealand pharmacy sector. Founded in 2006, the company previously operated as Corum Group before rebranding to Pharmx under CEO Tom Culver in 2023. Its core product, the Gateway, is a cloud-based EDI (Electronic Data Interchange) solution that integrates directly with 18+ pharmacy point-of-sale systems—including Fred, Minfos, Toniq, RxOne, Simple Retail, POSWorks, Pronto, and Corum Health—to automate ordering and e-invoicing between 5,500+ pharmacies and suppliers. A complementary B2B eCommerce Marketplace platform, launched in November 2025, enables multi-vendor product discovery and checkout, and the PharmX Analytics add-on provides predictive modelling, category analytics, natural-language querying, and unrealised-revenue tracking on top of the underlying transaction data.

The business serves two primary customer segments: (i) retail pharmacies across Australia and New Zealand (segment penetration of 99% in Australia per the company), and (ii) pharmaceutical and consumer health suppliers and wholesalers (including Bayer, Blackmores, Haleon, Pfizer, Reckitt, L'Oréal, and the major wholesalers CH2, API, and Symbion). Pharmacies access the platform free of charge; revenue is generated via account- and volume-based supplier partnership fees, supplemented by an exclusive contract with the National Diabetes Services Scheme (NDSS) for government diabetes product distribution.

Go-to-market combines self-serve platform access for SMB pharmacies and mid-market suppliers with direct enterprise sales for large pharmacy chains and major brand suppliers. Distribution is anchored by a February 2026 multi-year strategic alliance with Sigma Healthcare, under which Pharmx became the preferred EDI service provider for Sigma's wholesale operations and Chemist Warehouse retail footprint, accompanied by Sigma subscribing for ~10% of Pharmx's issued share capital and obtaining a board seat. The platform processes approximately $20 billion in annual pharmacy transactions across 80,000+ products, with exposure to all major Australian pharmacy banners (Chemist Warehouse, Priceline, Terrywhite Chemmart, Amcal, and Wizard).

PharmX firmographics

Firmographics
Name
PharmX
Legal name
Pharmx Technologies Limited
Website
https://pharmx.com.au
Company type
Public
Founded year
2006
Operating status
Operating
Headcount range
11–50 employees
Short description
PharmX Technologies (ASX: PHX) operates ANZ's leading pharmacy electronic ordering and invoicing platform, connecting 5,500+ pharmacies and major suppliers via EDI-integrated ordering, a B2B marketplace, and analytics tools, serving 99% of Australian pharmacies.
Ownership category
akta.pro rank

PharmX industry classification

Industry
Product category
Pharmacy Supply Chain Software
NAICS
Drugs and Druggists' Sundries Merchant Wholesalers (424210)
SIC
Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
akta.pro industry
PRIMARYHLACAKAI
Medication Inventory, Procurement & Supply Chain (Pharmacy)
Healthcare & Life Sciences/Digital Health & Health IT/ePrescribing, Medication Management & Pharmacy IT
SECONDARYCRAOAHAK
Pharmacy Benefit/Channel Services (PSAO, 340B Admin, Chargebacks/Rebates Ops)
SECONDARYHLAFALAI
Pharmacy Benefit Management (PBM) & Pharmacy Network Administration
Healthcare & Life Sciences/Healthcare Providers & Systems/Pharmacy & Medication Management Services

Keywords

  • Pharmacy ordering platform
  • Electronic data interchange
  • B2B eCommerce marketplace
  • Pharmaceutical supply chain
  • Point-of-sale integration

Where PharmX is headquartered

Location

Headquarters

HQ city
Sydney
HQ country
Australia
HQ region
Oceania

Offices1 record

Markets served

PharmX business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Supplier Partnership Fees: Pharmx's commercial model is funded through account and volume-based fees from supplier partnerships. Some suppliers may pass these fees on to pharmacies at their discretion.
  2. Strategic Alliance - Equity Investment: Under the multi-year strategic alliance with Sigma Healthcare, Pharmx receives equity investment (~59.95 million shares representing 10% of issued capital) and pays Sigma an establishment fee of approximately $8.7 million.

Pricing tiers

ModelBillingPrice
FreemiumMonthlyFree for pharmacies - platform access and ordering services provided at no cost

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

PharmX product offering

Product offering

Core offering

PharmX operates an integrated electronic ordering and invoicing platform for the Australian and New Zealand pharmacy industry. Its core offering is the Gateway, an EDI solution that connects pharmacies and suppliers through point-of-sale systems for automated ordering and e-invoicing. The company also operates a B2B Marketplace for multi-vendor product discovery and checkout, an Analytics platform for supplier insights, and a StockView inventory management tool.

Product overview

PharmX is a platform-plus-modules architecture providing integrated pharmacy ordering solutions across ANZ. The core products are the Gateway (EDI solution connecting pharmacies and suppliers through POS systems for automated ordering and e-invoicing) and the Marketplace (B2B eCommerce platform for product discovery and multi-vendor checkout). The Analytics module builds on these by leveraging the ordering data to deliver actionable insights including unrealised revenue tracking, category performance, and product catalogue enrichment. StockView adds inventory visibility. Together, these solutions facilitate over $20 billion in annual pharmacy transactions and provide access to 80,000+ products across 99% of Australian pharmacies.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

  • 99% of Australian pharmacies use the Pharmx platform
  • +5 more outcomes

Companies that use PharmX

Customer profile

Named customers6 records

Segments3 records

Ideal customer profiles4 records

PharmX technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration19 records

AI capability5 records

Feature6 records

PharmX partnerships and signals

Strategic signal

Partnerships

Seven partnerships are on record, tiered core and minor.

  • Sigma Healthcare LimitedcoreStrategic or Co-development Partner · 23 February 2026Multi-year strategic alliance positioning Pharmx as the preferred EDI service provider for Sigma's wholesale and Chemist Warehouse retail operations across Australia and New Zealand. Under the agreement, Sigma will subscribe for approximately 59.95 million Pharmx shares representing 10% of Pharmx's issued share capital and obtain a board seat. Pharmx will pay Sigma an establishment fee of approximately $8.7 million. The partnership aims to modernise pharmacy supply chains by improving reliability, efficiency, and transparency.
  • National Diabetes Services Scheme (NDSS)coreStrategic or Co-development PartnerPharmx holds an exclusive contract with the NDSS, supporting government agency distribution to pharmacies across Australia.
  • POS Vendors (Fred, Minfos, Toniq, RxOne, Simple Retail)coreTechnology or IntegrationPharmx integrates with all major point-of-sale vendors in the pharmacy industry including Fred, Minfos, Toniq, RxOne, and Simple Retail for seamless ordering and data synchronization.
  • Major Pharmacy Chains (Chemist Warehouse, Priceline, Terrywhite, Amcal, Wizard)coreChannel Partner/ Reseller/ DistributorMajor pharmacy retail chains use Pharmx for ordering and supply chain management including Chemist Warehouse, Priceline, Terrywhite Chemmart, Amcal, and Wizard.
  • Major Suppliers (Bayer, Blackmores, Haleon, Pfizer, Reckitt, L'Oréal)coreChannel Partner/ Reseller/ DistributorLeading pharmaceutical and consumer health brands distribute through Pharmx including Bayer, Blackmores, Haleon, Pfizer, Reckitt, L'Oréal, and many others.
  • Wholesalers (CH2, API, Symbion)coreChannel Partner/ Reseller/ DistributorMajor pharmaceutical wholesalers CH2, API, and Symbion connect to pharmacies through the Pharmx platform.
  • Pharmacy Groups (IPA, Chemsave, Chemist King, Discount Drug Stores, Pharmacy 777)minorChannel Partner/ Reseller/ DistributorVarious pharmacy buying groups and banner groups use Pharmx including IPA, Chemsave, Chemist King, Discount Drug Stores, and Pharmacy 777.

Scale indicators8 records

Recent moves5 records

Expansion highlights5 records

PharmX competitors and assessment

Company assessment

Direct peers

  • CoverMyMeds: CoverMyMeds (owned by McKesson) operates a leading US electronic prior authorization and benefit verification platform for pharmacies and prescribers. It is a directly comparable two-sided health IT platform monetising pharmacy-supplier-payer connectivity.
  • MedAdvisor: MedAdvisor (ASX: MDR) is an Australian digital medication management and patient adherence platform serving pharmacies. It targets the same ANZ pharmacy customer base as PharmX and competes for pharmacy technology wallet share, though focused on patient-facing workflows rather than procurement.
  • Surescripts: Surescripts operates the dominant US electronic prescribing network connecting prescribers, pharmacies, payers, and PBMs. Its two-sided health data exchange model and pharmacy-side integration footprint closely mirror PharmX's EDI/marketplace architecture for ANZ pharmacies.
  • PDX: PDX provides pharmacy software, clinical programs, and EDI/ordering technology solutions to US independent and chain pharmacies. Its pharmacy-facing ordering and supplier integration stack is functionally analogous to PharmX's Gateway offering.
  • RedSail Technologies: RedSail Technologies provides pharmacy management software, clinical solutions, and pharmacy supply chain technology across thousands of US independent pharmacies. Its combined dispensing and procurement technology footprint is closely comparable to PharmX's Gateway-plus-Marketplace model.

Broad incumbents

  • McKesson: McKesson is a global pharmaceutical wholesaler and owner of CoverMyMeds, with its own pharmacy ordering and supply chain platforms. It serves as the broad incumbent against which PharmX's ANZ-scale pharmacy network competes in capability breadth if not geographic overlap.
  • Cardinal Health: Cardinal Health is a leading US pharmaceutical wholesaler and operator of the OutcomesMTM and pharmacy services platforms. It is comparable as a broad incumbent integrating wholesale distribution with pharmacy technology and analytics.
  • Cencora: Cencora (formerly AmerisourceBergen) is a major US pharmaceutical distributor with embedded pharmacy services technology and Good Neighbor Pharmacy provider programs. It represents the broad incumbent equivalent of PharmX's supplier-pharmacy network at global scale.

Emerging players

  • RxBenefits: RxBenefits provides PBM technology, pharmacy benefit administration, and pharmacy supply chain analytics to employer health plans. It shares the supplier-pharmacy-payer data monetisation thesis with PharmX but focuses on US benefit administration rather than ordering infrastructure.
  • OrderInsite: OrderInsite is a US pharmacy inventory analytics and demand planning vendor serving chain and independent pharmacies. It overlaps with PharmX's newer Analytics/StockView modules, but lacks the EDI and marketplace layer.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat7 records

Key risks6 records

Key highlights7 records

Customer concentration

PharmX social profiles

Digital presence

PharmX compliance and trust

Trust signal

Compliance7 records

PharmX financial estimates

Financial estimate

Revenue estimate

Valuation estimate

PharmX leadership team

Management profile

Number of profiles

Profiles9 records

PharmX funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

PharmX M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about PharmX

What does PharmX do?

PharmX operates an integrated electronic ordering and invoicing platform for the Australian and New Zealand pharmacy industry. Its core offering is the Gateway, an EDI solution that connects pharmacies and suppliers through point-of-sale systems for automated ordering and e-invoicing. The company also operates a B2B Marketplace for multi-vendor product discovery and checkout, an Analytics platform for supplier insights, and a StockView inventory management tool.

Is PharmX a public or private company?

PharmX is a public company. It is classified as public and is currently operating.

When was PharmX founded?

PharmX was founded in 2006. It employs 11 to 50 people.

Where is PharmX based?

PharmX is headquartered in Sydney, Australia, in the Oceania region.

How does PharmX make money?

Two revenue lines are on record. Supplier Partnership Fees are the primary driver. The others are strategic Alliance - Equity Investment.

Who are PharmX's main competitors?

Direct peers on record are CoverMyMeds, MedAdvisor, Surescripts, PDX and RedSail Technologies. Broad incumbents are McKesson, Cardinal Health and Cencora. Emerging players are RxBenefits and OrderInsite.

Does PharmX have an API?

No public API is recorded for PharmX.

What industry is PharmX in?

PharmX's product category is Pharmacy Supply Chain Software. Its primary akta.pro industry code is HLACAKAI, Medication Inventory, Procurement & Supply Chain (Pharmacy), with a secondary code of CRAOAHAK, Pharmacy Benefit/Channel Services (PSAO, 340B Admin, Chargebacks/Rebates Ops). Its NAICS code is 424210 and its SIC code is 5122.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Investing.comPharmX at bell potter healthcare conference: push to monetize scalePharmX Technologies outlined plans to shift from flat account fees to percentage-based revenue at the Bell Potter Healthcare Conference. The company processes $26 billion in annual transactions but earns only $7.5 million, with its Marketplace platform running at a $100 million annualized rate. It targets $1 billion in annualized transaction value through Marketplace.Investing.comPharmX Q1 FY27 slides: marketplace GTV surges 150%, targets $100m run-ratePharmX reported Q1 FY27 revenue up 9% year-over-year, with marketplace gross transaction value surging 150% to A$6.9 million. The company targets A$100 million annualized marketplace run-rate by March 2027 and plans to launch Relay EDI in New Zealand and Australia.Seeking AlphaPharmX Technologies Limited (PHXTF) Q4 2026 Earnings Call TranscriptPharmX Technologies CEO Tom Culver opened the company's FY26 results presentation, outlining its infrastructure services for the ANZ pharmacy network and its FY27 focus areas. The company released a new Marketplace platform for pharmacy ordering and supplier channels, and is modernizing the PharmX Gateway. The Gateway, described as the sector's truth layer, facilitates $26 billion of network flows across 120,000 SKUs and over 300 million invoice lines annually.AInvestPharmX Technologies Ltd: PharmX renews national NDSS agreementPharmX Technologies Ltd has renewed its national agreement with the National Diabetes Services Scheme (NDSS), maintaining its role as a supplier of essential diabetes products to eligible patients across Australia. The renewal, which follows a period of supplier growth and operational momentum, is expected to provide stability for the company's business model reliant on government-supported channels. The terms and duration of the agreement have not been publicly disclosed.Retail PharmacyPharmx and Sigma partner to strengthen the digital infrastructure of the ANZ pharmacy sectorPharmx Technologies Limited has entered into a multi-year strategic alliance with Sigma Healthcare Limited, positioning Pharmx as the preferred EDI service provider for Sigma's wholesale and Chemist Warehouse retail operations across Australia and New Zealand. Under the agreement, Sigma will subscribe for approximately 59.95 million Pharmx shares, representing 10% of Pharmx's issued share capital, and obtain a board seat, while Pharmx will pay Sigma an establishment fee of approximately $8.7 million. The partnership aims to modernise pharmacy supply chains by improving reliability, efficiency, and transparency, with the first phase of the alliance commencing on 23 February 2026.